Apellis Pharmaceuticals, Inc. (APLS)

$ 40.39
   
  • Change Today:
    $0.16
  • 52 Week High: $40.42
  • 52 Week Low: $16.36
  • Currency: US Dollars
  • Shares Issued: 56.18m
  • Volume: 2,592
  • Market Cap: $2,269.03m
  • RiskGrade: 248
  • Beta: 0.03

APLS Overview

1 Day Chart (01-04-2026)

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

APLS Fundamentals

Fundamentals data is not available for this company.

APLS Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-26 866.42 (120.41) (112.70)¢ n/a n/a n/a n/a 0.0%
31-Dec-27 1,018.79 0.99 (22.72)¢ n/a n/a n/a n/a 0.0%

Copyright © 2026 FactSet Research Systems Inc. All rights reserved.

APLS ShareCast News

Biogen to buy Apellis Pharmaceuticals in $5.6bn ... 31-Mar-2026 ShareCast

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

APLS Market Data

Currency US Dollars
Share Price $ 40.39
Change Today $ 0.16
% Change 0.40 %
52 Week High $40.42
52 Week Low $16.36
Volume 2,592
Shares Issued 56.18m
Market Cap $2,269.03m
Beta 0.03
RiskGrade 248

What The Brokers Say

Strong Buy 6
Buy 8
Neutral 5
Sell 2
Strong Sell 0
Total 21
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 01-Apr-2026

Time Volume / Share Price
16:00 1,107,492 @ $40.39
15:59 200 @ $40.40
15:59 200 @ $40.40
15:59 200 @ $40.40
15:59 148 @ $40.40

Top of Page